Shengnuo Biotech (688117.SH) released its 2023 annual results report. During the reporting period, the company achieved operating income of 435 million yuan, an increase of 9.93%; net profit attributable to shareholders of listed companies was 703.371 million yuan, an increase of 9.08% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 60.208 million yuan, an increase of 6.38% year on year; basic income per share was 0.63 yuan. The company plans to distribute a cash dividend of 2.00 yuan (tax included) to all shareholders for every 10 shares.
圣诺生物 (688117.SH)发布2023年度业绩，净利润7033.71万元 同比增加9.08%
Shengnuo Biotech (688117.SH) announced its 2023 annual results, and net profit of 703.371 million yuan increased 9.08% year over year
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.